Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class
This study has been completed.
Sponsored by: Guidant Corporation
Information provided by: Guidant Corporation
ClinicalTrials.gov Identifier: NCT00292539
  Purpose

This registry is a data collection on patients who are implanted for more than 6 months with a pacemaker. Frequency and distribution of right ventricular pacing, NYHA class and left ventricular ejection fraction shall be documented.


Condition Intervention
Atrial Fibrillation
Bradycardia
Heart Block
Sick Sinus Syndrome
Device: Any pacemaker with right ventricular pacing option

Genetics Home Reference related topics: Brugada syndrome familial atrial fibrillation short QT syndrome
U.S. FDA Resources
Study Type: Observational
Study Design: Retrospective
Official Title: Preserve Registry: Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class

Further study details as provided by Guidant Corporation:

Estimated Enrollment: 600
Study Start Date: February 2006
Study Completion Date: September 2006
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Implanted pacemaker for more than 6 months, VVI/DDD, written consent

Exclusion Criteria:

  • Pacemaker implanted for less than 6 months, no right ventricular pacing possibility (AAI), no consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00292539

Locations
Germany
Kreiskrankenhaus
Viechtach, Germany, 94234
Sponsors and Collaborators
Guidant Corporation
Investigators
Study Director: Sven Treusch, PHD Guidant Corporation
  More Information

Responsible Party: Guidant Germany ( Sven Treusch )
Study ID Numbers: Preserve Registry
Study First Received: February 14, 2006
Last Updated: December 12, 2007
ClinicalTrials.gov Identifier: NCT00292539  
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Guidant Corporation:
Pacemaker
NYHA class
Ejection fraction
Heart Failure

Study placed in the following topic categories:
Heart Failure
Heart Diseases
Arrhythmia, Sinus
Heart Block
Bradycardia
Atrial Fibrillation
Sick Sinus Syndrome
Arrhythmias, Cardiac

Additional relevant MeSH terms:
Disease
Pathologic Processes
Syndrome
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 14, 2009